HMS
PBYI icon

Hanseatic Management Services’s Puma Biotechnology PBYI Stock Holding History

Hanseatic Management Services’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7
Closed -$1K – 476
2017
Q4 		$1K Sell
7
-29
-81% -$3.25K ﹤0.01% 388
2017
Q3 		$4K Sell
36
-5,210
-99% -$485K ﹤0.01% 279
2017
Q2 		$459K Buy
+5,246
New +$293K 0.23% 128
2016
Q4 		– Sell
-24,906
Closed -$1.67M – 362
2016
Q3 		$1.67M Buy
+24,906
New +$1.26M 0.6% 68
2014
Q4 		– Sell
-206
Closed -$49K – 384
2014
Q3 		$49K Buy
+206
New +$42.3K 0.03% 158

Other funds holding PBYI

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Hanseatic Management Services's PBYI Position: Q1 2018 in Review

Hanseatic Management Services sold out of Puma Biotechnology (PBYI) in Q1 2018, closing a stake of 7 shares — an estimated $1K sold.

Hanseatic Management Services first reported a position in PBYI in Q3 2014 and held it in 5 quarters. The position peaked at $1.67M in Q3 2016. 178 funds tracked by Wall St. Rank hold PBYI as of Q1 2018.

  • Hanseatic Management Services reported no remaining Puma Biotechnology position as of Q1 2018 after selling out during the quarter.
  • Hanseatic Management Services sold 7 Puma Biotechnology shares in Q1 2018, an estimated $1K.
  • Hanseatic Management Services first reported a position in Puma Biotechnology in Q3 2014 and held it in 5 quarters.
  • Hanseatic Management Services's Puma Biotechnology position peaked at $1.67M in Q3 2016.
  • 178 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2018.

Based on Hanseatic Management Services's 13F filing for Q1 2018, filed 2 May 2018.